期刊文献+

mfat-1小鼠胆固醇代谢特点及相关机制 被引量:1

The Characteristics of Cholesterol Metabolism and its Mechanism in mfat-1 Mice
下载PDF
导出
摘要 目的探讨mfat-1小鼠高脂饮食后血清胆固醇水平、胆固醇合成与吸收效率的改变及相关机制。方法mfat-1小鼠及C57BL/6小鼠各12只分别作为实验组和对照组,高脂饲料喂养4周后,心脏取血并取肝脏组织,气相色谱法检测小鼠肝脏膜脂质内二十碳五烯酸(EPA)、二十二碳六烯酸(DHA)、二十二碳五烯酸(DPA)、α-亚麻酸(ALA)、亚油酸(LA)、花生四烯酸(AA)的含量及血浆中总胆固醇、胆固醇合成标志物(角鲨烯、2,4-脱氢胆甾烷醇)及吸收标志物(菜油固醇、β-谷固醇、豆固醇)水平的变化,ELISA法检测两组小鼠肝脏中胆固醇合成限速酶3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-COAR)的表达水平。结果实验组小鼠肝脏膜脂质内ω-6/ω-3多不饱和脂肪酸(PUFA)比例显著低于对照组(1.70比6.04,P<0.01),血浆中胆固醇合成标志物角鲨烯、2,4-脱氢胆甾烷醇水平明显低于对照组(分别为0.63±0.17比1.24±0.36,3.89±0.54比6.57±1.06,P<0.05),胆固醇合成限速酶HMG-COAR的表达较对照组显著降低(379.76±22.37比443.98±27.99,P<0.01);胆固醇吸收标志物菜油固醇、β-谷固醇和豆固醇水平也显著低于对照组(分别为16.10±2.28比21.24±2.96、1.07±0.18比1.76±0.43、28.78±5.60比42.30±5.81,P<0.01);总胆固醇水平较对照组降低(0.91±0.07比1.16±0.85,P<0.01)。结论mfat-1小鼠通过抑制胆固醇的合成及吸收两种途径降低体内总胆固醇水平。 Aim To observe the change of serum total cholesterol( TC) and efficiency of the synthesis and absorption of cholesterol in the mfat-1 mice after high fat diet,and to explore the relative mechanism. Methods 12mfat-1 mice as experimental group and 12 C57BL / 6 mice as control group were given high fat diet for 4 weeks. Blood was taken from the heart,and the liver tissue extracted four weeks later. The content of liver lipids eicosapentaenoic acid( EPA),docosahexenoic acid( DHA),docosapentaenoic acid( DPA),α-linolenic acid( ALA),linoleic acid( LA),arachidonic acid( AA),serum TC,and the level of cholesterol synthesis markers( squalene,desmosterol),absorption markers( campesterol,β-sitosterol,stigmasterol),were determined with gas chromatogram. The express of cholesterol synthesis rate-limiting enzyme in liver,3-Hydroxy-3-methylglutaryl- coenzyme A reductase( HMG-COAR),were determined with ELISA. Results In the contents of liver membrance lipid,the ratio of ω-6 /ω-3 polyunsaturated fatty acids in the experimental group was significantly lower than that in the control group( 1. 70 vs 6. 04,P 0. 01). The levels of liver HMG-COAR in the experimental group were significantly lower than those in the control group( 379. 76 ± 22. 37 vs 443. 98± 27. 99,P 0. 01). The levels of plasma TC,cholesterol synthesis markers( squalene,desmosterol) and absorption markers( campesterol,β-sitosterol,stigmasterol) in the experimental group were significantly lower than those in the control group( 0. 91 ± 0. 07 vs 1. 16 ± 0. 85,P 0. 01; 0. 63 ± 0. 17 vs 1. 24 ± 0. 36,3. 89 ± 0. 54 vs 6. 57 ± 1. 06,P 0. 05;16. 10 ± 2. 28 vs 21. 24 ± 2. 96,1. 07 ± 0. 18 vs 1. 76 ± 0. 43,28. 78 ± 5. 60 vs 42. 30 ± 5. 81,P 0. 01,respectively).Conclusion The mfat-1 mice can inhibit cholesterol synthesis and absorption,thus decrease the total cholesterol.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2014年第5期459-462,共4页 Chinese Journal of Arteriosclerosis
基金 北京市自然科学基金(7112040)
关键词 Ω-3多不饱和脂肪酸 ω-6/ω-3多不饱和脂肪酸 胆固醇代谢标志物 3-羟基-3-甲基戊二酰辅酶A还原酶 ω-3 Poly Unsaturated Fat Tyacids ω-6/ω-3 Poly Unsaturated Fat Tyacids Cholesterol Metabolism Markers 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase
  • 相关文献

参考文献14

  • 1Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association StatisticsCommittee and Stroke Statistics Subcommittee[ J]. Circulation, 2008, 117 (4) : e25-146.
  • 2Bauchner H, Fontanarosa PB. The debut of dueling view- points[J]. JAMA, 2012, 307(14) : 1 532.
  • 3Kourounakis AP, Katselou MG, Matralis AN, et al. Squa- lene synthase inhibitors: An update on the search for new antihyperlipidemic and antiatherosclerotic agents [ J]. Curr Med Chem, 2011, 18(29) : 4 418-439.
  • 4Kang JX. A transgenic mouse model for gene-nutrient inter- actions [ J ]. J Nutrigenet Nutrigenomics, 2008, 1 :172-177.
  • 5ESC/EAS Guidelines for the management of dyslipidae- mias : the Task Force for the management of dyslipidaemias of the European Society of Cardiology ( ESC ) and the Euro- pean Atheroselerosis Society(EAS) [ J ]. Eur Heart, 2011, 3(214) : 1 769-818.
  • 6Bang HO, Dyerberg J, Hjoorne N. The composition of food consumed by Greenland Eskimos [ J ]. Acta Med Scand, 1976, 200: 69-73.
  • 7Hung P, Kaku S, Yunoki S, et al. Dietary effect of EPA rich and DHA rich fish oils on the immune function of Spra- gue-Dawley rats [ J]. Biosci Biotechnol Biochem, 1999, 63 ( 1 ) : 135-140.
  • 8Kourounakis AP, Katselou MG, Matralis AN, et al. Squa- lene synthase inhibitors: An update on the search for new antihyperlipidemic and antiatherosclerotic agents [ J ]. Curt Med Chem, 2011, 18(29) : 4 418-439.
  • 9刘洋,王绿娅,王启辉,张经华.体内胆固醇代谢标志物与血脂水平的相关性研究进展[J].中国动脉硬化杂志,2009,17(7):610-610. 被引量:4
  • 10欧海龙,严忠海,焦飞.利用RNA干扰技术抑制小鼠羟甲基戊二酸单酰辅酶A还原酶基因的表达[J].中国动脉硬化杂志,2013,21(2):129-134. 被引量:3

二级参考文献15

  • 1陈保生,李德岭,任渝棠.越低越好,越快越好?——他汀类药物强化降脂利弊谈[J].中国动脉硬化杂志,2006,14(9):737-740. 被引量:3
  • 2Fahed AC,Nemer GM. Familial hypercholesterolemia:the lipids or the genes[J].Nutrition and Metabolism,2011.23.
  • 3迟家敏.实用血脂学[M]北京:人民卫生出版社,2010392-393.
  • 4Al-Allaf FA,Coutelle C,Waddington SN. LDLR-gene therapy for familial hypercholesterolaemia:problems,progress,and perspectives[J].Int Arch Med,2010.36.
  • 5Van Craeyveld E,Jacobs F,Gordts SC. Gene therapy for familial hypercholesterolemia[J].Current Pharmaceutical Design,2011,(24):2575-2591.
  • 6Kankkonen HM,V(a)h(a)kangas E,Marr RA. Longterm lowering of plasma cholesterol levels in LDL-receptordeficient WHHL rabbits by gene therapy[J].Molecular Therapy,2004,(04):548-556.
  • 7Lebherz C,Gao G,Louboutin JP. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia[J].Journal of Gene Medicine,2004,(06):663-672.
  • 8Hibbitt OC,Harbottle RP,Waddington SN. Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection[J].Journal of Gene Medicine,2007,(06):488-497.
  • 9Hibbitt OC,McNeil E,Lufino MM. Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs[J].Molecular Therapy,2010,(02):317-326.
  • 10Hibbitt O,Agkatsev S,Owen C. RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo[J].Gene Therapy,2012,(04):463-467.

共引文献5

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部